Literature DB >> 16616867

Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures.

Noriyoshi Mizuno1, Hideki Shiba, Yoshitaka Ozeki, Yoshihiro Mouri, Miyuki Niitani, Takafumi Inui, Hideaki Hayashi, Koji Suzuki, Seishin Tanaka, Hiroyuki Kawaguchi, Hidemi Kurihara.   

Abstract

The major problem in cell therapy is the possibility of viral or bacterial infection and immune reactions. Therefore, it is expected of culture cells which are intended to be re-implanted with autologous serum rather than conventional bovine serum. Cell therapy with human mesenchymal stem cells (hMSC), differentiating to various cells, is thought to be curative. To culture hMSC with human autologous serum (HAS) and re-implant them for cell therapy, we developed a completely closed bag system separating serum, comparing proliferation and multipotency of hMSC cultured in HAS with those in foetal calf serum (FCS). HAS was simply, safely and efficiently obtained with the developed closed bag system. Cell proliferation of hMSC cultured in HAS was greater than that in FCS. hMSC, exposed to the defined induction medium containing HAS as well as FCS, differentiated into osteoblasts and adipocytes. These findings suggest that HAS obtained with the developed closed bag system is advantageous in a point of decrease in risk of virus or bacterial infection and foreign protein contamination and enhancement of proliferation of hMSC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616867     DOI: 10.1016/j.cellbi.2006.01.010

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  20 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Derivation, expansion and characterization of clinical grade mesenchymal stem cells from umbilical cord matrix using cord blood serum.

Authors:  Khushnuma Cooper; Anish SenMajumdar; Chandra Viswanathan
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

3.  A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.

Authors:  Suneel Rallapalli; Soma Guhathakurta; Dillip Kumar Bishi; Rajasekaran Subbarayan; Santosh Mathapati; Purna Sai Korrapati
Journal:  Biotechnol Lett       Date:  2021-09-09       Impact factor: 2.461

4.  "Humanized" stem cell culture techniques: the animal serum controversy.

Authors:  Chandana Tekkatte; Gency Ponrose Gunasingh; K M Cherian; Kavitha Sankaranarayanan
Journal:  Stem Cells Int       Date:  2011-04-03       Impact factor: 5.443

5.  Epidermal growth factor promotes the differentiation of stem cells derived from human umbilical cord blood into neuron-like cells via taurine induction in vitro.

Authors:  Wei Jin; Yi-qiao Xing; An-huai Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-02-27       Impact factor: 2.416

Review 6.  Mesenchymal stem cell-based therapy for cartilage repair: a review.

Authors:  Hideyuki Koga; Lars Engebretsen; Jan E Brinchmann; Takeshi Muneta; Ichiro Sekiya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-03-31       Impact factor: 4.342

7.  Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.

Authors:  Sunghoon Jung; Krishna M Panchalingam; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cells Int       Date:  2012-05-07       Impact factor: 5.443

8.  Mesenchymal Stem Cells from Bichat's Fat Pad: In Vitro Comparison with Adipose-Derived Stem Cells from Subcutaneous Tissue.

Authors:  Eugenio Broccaioli; Stefania Niada; Giulio Rasperini; Lorena Maria Ferreira; Elena Arrigoni; Vijay Yenagi; Anna Teresa Brini
Journal:  Biores Open Access       Date:  2013-04

Review 9.  Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review.

Authors:  Krishna M Panchalingam; Sunghoon Jung; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cell Res Ther       Date:  2015-11-23       Impact factor: 6.832

10.  A novel endometriosis inducing factor in women with endometriosis.

Authors:  K Rasheed; H Atta; Tf Taha; O Azmy; D Sabry; M Selim; A El-Sawaf; M Bibars; A Ramzy; W El-Garf; M Anwar
Journal:  J Stem Cells Regen Med       Date:  2010-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.